A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs

NCT00620425 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Sumatriptan

Sponsor

Zogenix, Inc.